From: High frequency of methicillin-resistant Staphylococcus aureus in Peshawar Region of Pakistan
Antimicrobial drugs | Drug susceptibility | MRSA n (%) | MSSA n (%) | p value |
---|---|---|---|---|
Penicillin (10 µg) | Susceptible | 0 (0) | 0 (0) | 1 |
Resistant | 101 (100) | 179 (100) | ||
Amikacin (30 µg) | Susceptible | 52 (51.5) | 179 (100) | <0.0001 |
Resistant | 49 (48.5) | 0 (0) | ||
Chloramphenicol (30 µg) | Susceptible | 78 (77.2) | 179 (100) | <0.0001 |
Resistant | 23 (22.8) | 0 (0) | ||
Ciprofloxacin (5 µg) | Susceptible | 20 (19.8) | 137 (76.5) | <0.0001 |
Resistant | 81 (80.2) | 42 (23.7) | ||
Cefoxitin (30 µg) | Susceptible | 0 (0) | 179 (100) | <0.0001 |
Resistant | 101 (100) | 0 (0) | ||
Erythromycin (15 µg) | Susceptible | 01 (0.99) | 54 (30.2) | <0.0001 |
Resistant | 100 (99.01) | 125 (69.8) | ||
Gentamicin (10 µg) | Susceptible | 44 (43.6) | 167 (93.3) | <0.0001 |
Resistant | 57 (56.4) | 12 (6.7) | ||
Clindamycin (2 µg) | Susceptible | 76 (75.2) | 177 (98.9) | <0.0001 |
Resistant | 25 (24.8) | 2 (1.1) | ||
Minocycline (30 µg) | Susceptible | 68 (67.3) | 115 (64.3) | 0.603 |
Resistant | 33 (32.7) | 64 (35.7) | ||
Doxycycline (30 µg) | Susceptible | 59 (58.4) | 81 (45.3) | 0.034 |
Resistant | 42 (41.6) | 98 (54.7) | ||
Cotrimoxazole (1.25/23.75 µg) | Susceptible | 67 (65.3) | 167 (93.3) | <0.0001 |
Resistant | 34 (33.7) | 12 (6.7) | ||
Linezolid (30 µg) | Susceptible | 101 (100) | 179 (100) | 1 |
Resistant | 0 (0) | 0 (0) | ||
Fusidic acid (10 µg) | Susceptible | 60 (59.4) | 148 (82.7) | <0.0001 |
Resistant | 41 (40.6) | 31 (17.3) | ||
Rifampicin (5 µg) | Susceptible | 82 (81.2) | 179 (100) | <0.0001 |
Resistant | 19 (18.8) | 0 (0) | ||
Vancomycin (30 µg) | Susceptible | 101 (100) | 179 (100) | 1 |
Resistant | 0 (0) | 0 (0) | ||
Moxifloxacin (5 µg) | Susceptible | 15 (14.9) | 174 (97.2) | <0.0001 |
Resistant | 86 (85.1) | 5 (2.8) |